Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Liver Cirrhosis - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Liver Cirrhosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Cytomegalovirus (HHV-5) Infections - Global Clinical Trials Review, 2024
... provides top line data relating to the clinical trials on Cytomegalovirus (HHV-5) Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage ... Read More
-
Clinical Trial Supply and Logistics Market for Pharma 2024-2034
... wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Advancing ... Read More
-
Androgenic Alopecia: Competitive Landscape
... AGA are anticipated in the 16 countries covered in GlobalData’s epidemiology forecast for AGA. Most marketed drugs for AGA are enzyme inhibitors followed by ion channel activators. The AGA pipeline has a limited number of ... Read More
-
Spinal Cord Injury: Competitive Landscape
... incident cases of SCI are anticipated in the 16 countries covered in GlobalData’s epidemiology forecast for SCI. There is a high unmet need for treating patients with SCI, currently the market comprises many generics and ... Read More
-
Vitiligo: Competitive Landscape
... anticipated in the 16 countries covered in GlobalData’s epidemiology forecast for Vitiligo. There is a high unmet need for treating patients with vitiligo, as there is only one approved innovator product in the market. The ... Read More
-
Genital Herpes: Competitive Landscape
... of HSV-2 infection are anticipated in the 16 countries covered in GlobalData’s epidemiology forecast for GH. Nucleoside analogue antiviral drugs have been the mainstay of GH treatment for over two decades. The GH pipeline has ... Read More
-
Global Clinical Trial Supplies Market 2024-2028
... clinical trial supplies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Asthma Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... billion by 2029, growing at a CAGR of 5.88% during the forecast period (2024-2029). Factors such as an increase in the incidence and prevalence of asthma, the growing geriatric population, and technological advancements are boosting ... Read More
-
Bronchiectasis: Opportunity Assessment and Forecast
... given diagnostic code of J47.9 from the International Classification of Diseases, Tenth Edition (ICD-10), is defined by damage to the bronchi, causing abnormal dilation and scarring. The airways become inflamed with thick mucus that is ... Read More
-
Adult Myopia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
... to reach US$ 256.9 Million by 2034, exhibiting a growth rate (CAGR) of 3.44% during 2024-2034. The adult myopia market has been comprehensively analyzed in IMARC's new report titled "Adult Myopia Market: Epidemiology, Industry Trends, ... Read More
-
Cell & Gene Therapy Clinical Trial Services Market – By Service (Clinical Trial Design & Planning), Phase, Indication, Therapy Type (Gene, Cell, Gene Modified Cell Therapy), End-use (Pharmaceutical & Biotechnology, CRO) – Global Forecast (2024 2032)
... 2032) Global Cell & Gene Therapy Clinical Trial Services Market size will expand at a 10.8 CAGR from 2024 to 2032, attributed to technological upgrades, such as CRISPR-Cas9 and viral vectors, in line with ... Read More
-
Gastroesophageal Reflux Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
... market has been comprehensively analyzed in IMARC's new report titled "Gastroesophageal Reflux Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034". Gastroesophageal reflux disease refers to a common, chronic condition characterized by ... Read More
-
Clinical Trial Biorepository & Archiving Solutions Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service (Biorepository Services, Archiving Solution Services), By Product (Preclinical Products, Clinical Products), By Region and Competition, 2019-2029F
... Global Clinical Trial Biorepository & Archiving Solutions Market was valued at USD 3.52 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 6.41% through 2029. Clinical ... Read More
-
Pemphigus Vulgaris Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
... to reach US$ 519.4 Million by 2034, exhibiting a growth rate (CAGR) of 6.3% during 2024-2034. The pemphigus vulgaris market has been comprehensively analyzed in IMARC's new report titled "Pemphigus Vulgaris Market: Epidemiology, Industry Trends, ... Read More
-
Multiple Myeloma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
... to reach US$ 38.1 Billion by 2034, exhibiting a growth rate (CAGR) of 8% during 2024-2034. The multiple myeloma market has been comprehensively analyzed in IMARC’s new report titled “Multiple Myeloma Market: Epidemiology, Industry Trends, ... Read More
-
Wet Age-Related Macular Degeneration (Wet AMD) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
... 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 16,864.9 Million by 2034, exhibiting a growth rate (CAGR) of 5.9% during 2024-2034. Wet Age-Related Macular Degeneration (Wet AMD) market is currently driven by ... Read More
-
Encephalitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
... US$ 23.4 Billion by 2034, exhibiting a growth rate (CAGR) of 4.1% during 2024-2034. The encephalitis market has been comprehensively analyzed in IMARC's new report titled "Encephalitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, ... Read More
-
Complicated Urinary Tract Infections (cUTIs) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
... The complicated urinary tract infections (cUTIs) market has been comprehensively analyzed in IMARC's new report titled "Complicated Urinary Tract Infections (cUTIs) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034". Complicated urinary tract ... Read More
-
Sexually Transmitted Diseases Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
... the 7MM to reach US$ 95.0 Billion by 2034, exhibiting a growth rate (CAGR) of 8.01% during 2024-2034. The sexually transmitted diseases market has been comprehensively analyzed in IMARC's new report titled "Sexually Transmitted Diseases ... Read More
-
Myopia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
... IMARC's new report titled "Myopia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034". Myopia, also known as nearsightedness, refers to a refractive error of the eye that makes distant objects appear blurry ... Read More
-
Hereditary Angioedema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034
... to reach US$ 3.5 Billion by 2034, exhibiting a growth rate (CAGR) of 6.1% during 2024-2034. Hereditary Angioedema Market is currently witnessing strong growth driven by advances in identifying mechanisms of angioedema and developing modern ... Read More
-
Hypophosphatasia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
... US$ 1,036.4 Million by 2034, exhibiting a growth rate (CAGR) of 3.3% during 2024-2034. The hypophosphatasia market has been comprehensively analyzed in IMARC's new report titled "Hypophosphatasia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, ... Read More
-
Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type, By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user, By Region, And Segment Forecasts, 2024 - 2030
... Clinical Trials Management System Market Growth & Trends The global clinical trials management system market size is anticipated to reach USD 4.73 billion by 2030 and is projected to grow at a CAGR of 14.65% ... Read More
-
Clinical Trials Packaging Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... was valued at USD 3.80 billion in 2023 and is projected to grow from USD 4.13 billion in 2024 to USD 8.54 billion by 2032, exhibiting a CAGR of 9.51% during the forecast period of ... Read More
Research Assistance
